<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">249</article-id><article-id pub-id-type="publisher-id">2008MOLVIS003</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Differential neuroglycan C expression during retinal degeneration in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Escher</surname><given-names>Pascal</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cottet</surname><given-names>Sandra</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aono</surname><given-names>Saichiko</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oohira</surname><given-names>Atsuhiko</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schorderet</surname><given-names>Daniel F.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><aff id="aff1"><label>1</label>Institute for Research in Ophthalmology, Sion, Switzerland</aff><aff id="aff2"><label>2</label>Department of Ophthalmology, University of Lausanne, Lausanne, Switzerland</aff><aff id="aff3"><label>3</label>Department of Perinatology, Institute for Developmental Research, Aichi Human Service Center, Kasugai, Japan</aff><aff id="aff4"><label>4</label>EPFL-Ecole Polytechnique F&#x000e9;d&#x000e9;rale, Lausanne, Switzerland</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Dr. Pascal Escher, IRO-Institut de Recherche en Ophtalmologie, Grand-Champsec 64 CH-1950, Sion, Switzerland; Phone: ++41 (0)27 205 79 02; FAX: ++41 (0)27 205 79 01; email: <ext-link ext-link-type="uri" xlink:href="mailto:pascal.escher@irovision.ch">pascal.escher@irovision.ch</ext-link></corresp></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>26</day><month>11</month><year>2008</year></pub-date><volume>14</volume><fpage>2126</fpage><lpage>2135</lpage><history><date date-type="received"><day>02</day><month>1</month><year>2008</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2008</year></date></history><permissions><copyright-year>2008</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>An increased mRNA expression of the genes coding for the extracellular matrix proteins neuroglycan C (<italic>NGC</italic>), interphotoreceptor matrix proteoglycan 2 (<italic>IMPG2</italic>), and CD44 antigen (<italic>CD44</italic>) has been observed during retinal degeneration in mice with a targeted disruption of the <italic>Rpe65</italic> gene (<italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mouse). To validate these data, we analyzed this differential expression in more detail by characterizing retinal <italic>NGC</italic> mRNA isoform and protein expression during disease progression.</p></sec><sec sec-type="methods"><title>Methods</title><p>Retinas from C57/Bl6 wild-type and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice, ranging 2 to 18 months of age, were used. <italic>NGC</italic>, <italic>IMPG2</italic>, and <italic>CD44</italic> mRNA expression was assessed by oligonucleotide microarray, quantitative PCR, and in situ hybridization. Retinal NGC protein expression was analyzed by western blot and immunohistochemistry.</p></sec><sec><title>Results</title><p>As measured by quantitative PCR, mRNA expression of <italic>NGC</italic> and <italic>CD44</italic> was induced by about 2 fold to 3 fold at all time points in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas, whereas initially 4 fold elevated <italic>IMPG2</italic> mRNA levels progressively declined. <italic>NGC</italic> and <italic>IMPG2</italic> mRNAs were expressed in the ganglion cell layer, the inner nuclear layer, and at the outer limiting membrane. <italic>NGC</italic> mRNA was also detected in retinal pigment epithelium cells (RPE), where its mRNA expression was not induced during retinal degeneration. <italic>NGC-I</italic> was the major isoform detected in the retina and the RPE, whereas <italic>NGC-III</italic> was barely detected and <italic>NGC-II</italic> could not be assessed. NGC protein expression was at its highest levels on the apical membrane of the RPE. NGC protein levels were induced in retinas from 2- and 4-month-old <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice, and an increased amount of the activity-cleaved NGC ectodomain containing an epidermal growth factor (EGF)-like domain was detected.</p></sec><sec><title>Conclusions</title><p>During retinal degeneration in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice, NGC expression is induced in the neural retina, but not in the RPE, where NGC is expressed at highest levels.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Leber congenital amaurosis (LCA) is a genetically heterogeneous retinal dystrophy with prenatal onset. A subset of patients carries mutations in the retinal pigment epithelium protein of 65 kDa (<italic>RPE65</italic>) gene (LCA2; OMIM #<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=204100">204100</ext-link>) [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r2">2</xref>]. RPE65 is the iron (II)-dependent isomerohydrolase essential for the generation of the photopigment 11-cis retinal from all-trans-retinyl ester in the retinoid visual cycle [<xref ref-type="bibr" rid="r3">3</xref>-<xref ref-type="bibr" rid="r6">6</xref>]. In the RPE of mice with a targeted disruption of the <italic>Rpe65</italic> gene (<italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice), no 11-<italic>cis</italic> retinal has been synthesized, and excessive accumulation of all-<italic>trans</italic> retinyl esters has been observed [<xref ref-type="bibr" rid="r7">7</xref>]. This enzymatic defect in the RPE was found to result in profound effects in the underlying photoreceptors. Cone photoreceptor degeneration was found to be complete within the first postnatal weeks in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice, whereas rod photoreceptor degeneration progressed slowly [<xref ref-type="bibr" rid="r8">8</xref>,<xref ref-type="bibr" rid="r9">9</xref>]. Early cone loss was reflected by a rapid decrease in cone-specific gene expression [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r11">11</xref>].</p><p>The gene coding for the interphotoreceptor matrix (IPM) proteoglycan 2 (<italic>IMPG2</italic>) was induced in retinas of <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice [<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r12">12</xref>]. The IPM is a specialized extracellular matrix of fundamental importance to vision, e.g., in trafficking of retinoids and other metabolites between photoreceptors and the RPE, and in retinal adhesion or in photoreceptor outer segment recognition for phagocytosis [<xref ref-type="bibr" rid="r13">13</xref>]. It has been proposed that proteoglycans containing hyaluronic acid-binding motifs, e.g., IMPG2, IMPG1, and CD44, a cell surface adhesion molecule specifically localized in the M&#x000fc;ller cell microvilli that oppose the IPM [<xref ref-type="bibr" rid="r14">14</xref>], stabilize a scaffold of hyaluronic acid in the IPM [<xref ref-type="bibr" rid="r15">15</xref>]. Interestingly, increased <italic>CD44</italic> mRNA levels have also been observed in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas [<xref ref-type="bibr" rid="r11">11</xref>].</p><p>Additionally, expression of the transmembrane neuronal proteoglycan with chondroitin sulfate (NGC: neuroglycan C; also called CALEB: chicken acidic leucine-rich EGF-like domain containing brain protein; CSPG5: chondroitin sulfate proteoglycan 5) has also been induced in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas [<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r17">17</xref>]. Chondroitin sulfate side chains become attached to the NGC core protein in the developing rat cerebellum and retina, but not the adult ones [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>]. NGC has therefore been described as a part-time proteoglycan. In the central nervous system, NGC has been found to be associated with both glial and neuronal surfaces [<xref ref-type="bibr" rid="r17">17</xref>]. In the retina, NGC is highly expressed on the axons of the nerve fiber layer and the inner plexiform layer at early postnatal stages (between P0 and P14), when active dendrite branching and conventional synapses between amacrine cells and ganglion cells can be observed in the inner retinal layers [<xref ref-type="bibr" rid="r19">19</xref>]. At late postnatal and adult stages (between P14 and P42), when synapse formation and dendrite branching are almost complete, NGC expression was found to be reduced [<xref ref-type="bibr" rid="r19">19</xref>]. NGC was localized to basal infoldings at P7 and to microvillis of the apical surface in the adult retina (P42) [<xref ref-type="bibr" rid="r19">19</xref>], indicating that high NGC expression in the RPE is differentially regulated during development. Neuronal depolarization of chick retinal cells in culture was shown to facilitate the processing of full-length NGC into a truncated transmembrane form and an ectodomain [<xref ref-type="bibr" rid="r20">20</xref>]. This activity-dependent ectodomain shedding exposed the EGF-like domain, located in the C-terminus of the ectodomain of NGC [<xref ref-type="bibr" rid="r20">20</xref>]. Interestingly, a recombinant ectodomain promoted neurite outgrowth from rat neocortical neurons in culture [<xref ref-type="bibr" rid="r21">21</xref>] and mediated dendritic tree and spine complexity in vivo [<xref ref-type="bibr" rid="r22">22</xref>].</p><p>The aim of this study was to validate and characterize the NGC expression during retinal degeneration in <italic>Rpe65<sup>-/-</sup></italic> mice. Additionally, we assessed the expression of IMPG2 and CD44.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Animal handling</title><p>All experiments performed in this study were in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the Veterinary Service of the State of Valais (Switzerland). C57BL/6 mice (RCC, Basel, Switzerland) and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice [<xref ref-type="bibr" rid="r7">7</xref>] were kept in a 12 h:12 h light-dark cycle with unlimited access to food and water until they were used for experiments.</p></sec><sec><title>RNA preparation</title><p>Mice were killed by cervical dislocation. Eyes were enucleated, immobilized with 0.2&#x000a0;mm Austerlitz insect pins (Fine Science Tools, Heidelberg, Germany) on a Sylgard 184-filled cell culture dish (Dow Corning, Midland, MI), and covered with 1X PBS (phosphate-buffered saline: 154 mM NaCl, 1 mM KH<sub>2</sub>PO<sub>4</sub> , 3 mM Na<sub>2</sub>HPO<sub>4</sub> heptahydrate). Under a Leica 16MZF microscope (Leica Microsystems, Heerbrugg, Switzerland), the eyeball was sectioned below the ora serrata to remove cornea, lens, iris, and other attached tissues. The retina was then removed by cutting the optic nerve. For quantitative PCR experiments, pure RPE cells were obtained by trypsin-digestion from the posterior eyecup [<xref ref-type="bibr" rid="r23">23</xref>]. Briefly, the posterior eyecup comprised of RPE, choriocapillaris, and sclera was incubated in 0.2% trypsin (Invitrogen, Basel, Switzerland) for 1 h at 37 &#x000b0;C in a 5% CO2 atmosphere. Then, RPE cells were gently peeled off with forceps. For RT&#x02013;PCR experiments, the sclera was dissociated from the RPE and attached choroidal tissue through homogenization with 18 gauge Sterican needles (Braun, Melsungen, Germany) in TRIzol (Invitrogen). Dissociated RPE with attached choroid was separated from the sclera by centrifugation at 1000x g and stored at &#x02212;80&#x000a0;&#x000b0;C. Total RNA from the different dissected eye tissues was prepared according to manufacturer&#x02019;s instructions, with prolonged centrifugation times to increase RNA recovery.</p></sec><sec><title>Oligonucleotide microarray</title><p>The oligonucleotide microarray was previously described in detail [<xref ref-type="bibr" rid="r11">11</xref>]. Briefly, three retinas were pooled for each time point. Total RNA (1 &#x003bc;g) was used to generate doublestranded cDNA used as a template for biotinylated cRNA synthesis using Affymetrix GeneChip Expression 3&#x02032;-Amplification Kit for IVT Labeling Kit (Affymetrix, Santa Clara, CA). Next, 20 &#x003bc;g of target cRNA were fragmented and hybridized on Affymetrix Mouse Genome 430 2.0 GeneChips, and washed chips were scanned on an Affymetrix GeneChip Scanner 3000 using the GCOS software (Affymetrix). Data normalization was performed using the Robust Multi-Array Analysis algorithm (RMA) as implemented in the GeneSpring 7.2 software (Agilent Technologies, Santa Clara, CA). Triplicates were performed for each condition studied. The intensity files corresponding to our raw data are deposited in NCBI Gene Expression Omnibus (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo">GEO</ext-link>) database.</p></sec><sec><title>PCR</title><p>Total RNA (2 &#x003bc;g) were used for reverse transcription (StrataScript&#x02122;; Stratagene, La Jolla, CA). One-tenth of the reaction was used for subsequent PCR experiments. After an initial denaturation of 3 min at 94&#x000a0;&#x000b0;C, a 30 cycle PCR amplification was performed as follows: 30 s at 94&#x000a0;&#x000b0;C, 30 s at 60&#x000a0;&#x000b0;C, and 45 s at 72&#x000a0;&#x000b0;C. Amplification was followed by a final elongation of 5 min at 72&#x000a0;&#x000b0;C (Taq PCR Master Mix ; Qiagen, Hilden, Germany). Expression of the ribosomal protein L8 (RL8) was used as internal standard [<xref ref-type="bibr" rid="r24">24</xref>]. PCR products were analyzed on 2% agarose gels. Quantitative PCR was performed on an Mx3000p sequence analyzer using Brilliant&#x000ae;SYBR&#x000ae;Green qPCR Master Mix I (Stratagene). Experimental data points with cycle threshold (C<sub>t</sub>) values above 30 were not considered for data analysis. Primers are listed in <xref ref-type="table" rid="t1">Table 1</xref>.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Primers for PCR.</title></caption><table frame="hsides" rules="groups"><col width="45" span="1"/><col width="162" span="1"/><col width="144" span="1"/><col width="54" span="1"/><col width="45" span="1"/><tbody><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1"><bold>Gene/ isoform</bold><hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1"><bold>Forward primer (5&#x02032;-3&#x02032;)</bold><hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1"><bold>Reverse primer (5&#x02032;-3&#x02032;)</bold><hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1"><bold>GenBank accession number</bold><hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1"><bold>Location (nt)</bold><hr/></td></tr><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1"><italic>NGC</italic><hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">GACTGAGAATACCAAGCTGC<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">TTGGGTGACATGGAGTTCTG<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=34328223">NM_013884</ext-link><hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">1500/1700<hr/></td></tr><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1"><italic>NGC-I</italic><hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">AGTGCTGCTGCTTCTGGGGGTCA<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">TTATCATGGACAGCAGGGGA<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=34328223">NM_013884</ext-link><hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">192/644<hr/></td></tr><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1"><italic>NGC-II</italic><hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">ATTTGGGGCGGGAAACCATA<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">TTATCATGGACAGCAGGGGA<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=34328223">NM_013884</ext-link><hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">&#x02212;98/644<hr/></td></tr><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1"><italic>NGC-III</italic><hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">CTCCACAACGACAACTTCTC<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">AGAGGGTCCTGGATTTTGTG<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=34328223">NM_013884</ext-link><hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">1552/1643<hr/></td></tr><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1"><italic>IMPG2</italic><hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">CTTCTGCTGTCGTCTTCTTC<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">CCAATCACCTCTTCACTAGC<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=28981394">BC048863</ext-link><hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">3544/3769<hr/></td></tr><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1"><italic>CD44</italic><hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">CTCAGATTCCAGAATGGCTC<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1">TCAGCTGTCATACACTGGTC<hr/></td><td valign="bottom" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=85540470">NM_009851</ext-link><hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">2367/2616<hr/></td></tr><tr><td valign="bottom" align="center" scope="row" rowspan="1" colspan="1"><italic>RL8</italic></td><td valign="bottom" align="left" rowspan="1" colspan="1">ACTGGACAGTTCGTGTACTG</td><td valign="bottom" align="left" rowspan="1" colspan="1">GCTTCACTCGAGTCTTCTTG</td><td valign="bottom" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=6755357">NM_012053</ext-link></td><td valign="bottom" align="center" rowspan="1" colspan="1">271/469</td></tr></tbody></table><table-wrap-foot><p>The location of the PCR amplification products is indicated with respect to nucleotide numbering of the indicated GenBank accession numbers. The location of the <italic>NGC-II</italic>-specific forward primer was according to the publicly available genomic sequence of chromosome 9 (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org">ensembl</ext-link>, release 49) and by defining the A of the initial ATG of the coding sequence as nt 1.</p></table-wrap-foot></table-wrap></sec><sec><title>In situ hybridization</title><p>Eyes were enucleated, rinsed in diethyl-pyrocarbonate (DEPC)-treated 1X PBS and fixed for 2 h with 4% paraformaldehyde-1X PBS-DEPC at 4&#x000a0;&#x000b0;C. After cryoprotection by immersion in 30% sucrose-1X PBS-DEPC, overnight at 4&#x000a0;&#x000b0;C, eyes were embedded in freezing compound (30% albumin/3% gelatine in DEPC-treated 1X PBS). Eyes were sectioned at &#x02212;21&#x000a0;&#x000b0;C on a Leica CM1900 cryostat, and 12 &#x003bc;m sections were recovered on SuperFrost&#x000ae;Plus microscope slides (Menzel Gl&#x000e4;ser, Braunschweig, Germany) pretreated with Vectabond (Vector Laboratories, Burlingame, CA). PCR fragments of <italic>NGC</italic> and <italic>IMPG2</italic> cDNAs, amplified with primers shown in <xref ref-type="table" rid="t1">Table 1</xref>, were subcloned into the pGEM&#x000ae;-T Easy Vector (Promega, Madison, WI). Plasmids were linearized with XbaI or NcoI for probe synthesis. Digoxygenin (DIG)-labeled sense and antisense probes were tested by immunodot blotting and equal amounts of probe used in the experiment [<xref ref-type="bibr" rid="r25">25</xref>]. In situ hybridizations were performed as previously described, including a carbamoylation step in active 0.1% DEPC-1X PBS at a hybridization temperature of 48&#x000a0;&#x000b0;C [<xref ref-type="bibr" rid="r25">25</xref>].</p></sec><sec><title>Immunohistochemistry</title><p>Eyes were enucleated and fixed in 4% paraformaldehyde-1X PBS for 2 h at 4&#x000a0;&#x000b0;C. After cryoprotection by immersion in 30% sucrose-1X PBS overnight at 4&#x000a0;&#x000b0;C, eyes were embedded in freezing compound (30% albumin/3% gelatine in 1X PBS). For immunohistochemistry, 12 &#x003bc;m cryosections were collected on Superfrost&#x000ae;Plus glass slides (Menzel,). Sections were dried at room temperature for at least 1 h, quickly hydrated with 1X PBS, and blocked for 1 h in 1X PBS containing 2% goat serum and 0.2% Triton X-100. A rabbit polyclonal serum raised against the extracellular domain of rat NGC was diluted at 1:500 in blocking solution and incubated overnight at 4&#x000a0;&#x000b0;C [<xref ref-type="bibr" rid="r26">26</xref>]. Sections were then briefly rinsed twice with blocking solution and washed once for 5 min. Secondary antibodies conjugated to Alexa Fluor 594 (Molecular Probes, Invitrogen) were diluted at 1:1,000 and incubated for 1 h at room temperature in the dark. Sections were rinsed briefly twice in 1X PBS then washed three times for 5 min. Parts of sections were stained with DAPI to visualize nuclei. To stain cone photoreceptor outer segments, we used 20&#x000a0;&#x003bc;g/ml fluorescein-conjugated peanut agglutinin (Sigma-Fluka, Buchs, Switzerland). Slides were washed three times for 5 min in 1X PBS, before mounting in Cityfluor (Cityfluor Ltd., London,UK).</p></sec><sec><title>Western blotting</title><p>On ice, four mouse retinas were homogenized with a plastic pestle in 200&#x000a0;&#x003bc;l of a buffer containing 100&#x000a0;mM NaCl, 50&#x000a0;mM Tris pH 7.5, 1&#x000a0;mM EDTA, 0.1% Triton X-100, 10&#x000a0;mM NaF, and freshly added proteinase inhibitors (Complete; Roche, Basel, Switzerland). Protein extracts were stored at &#x02212;80&#x000a0;&#x000b0;C. For western blotting, 20&#x000a0;&#x003bc;g of protein extracts were separated on a 5% stacking gel and a 6% resolving gel. Proteins were transferred onto a polyvinlyidenfluoride (PVDF) membrane (Westran&#x000ae; Clear Signal; GE Healthcare, Piscataway, NJ). Membranes were blocked for 1 h in TBS-Tween containing 5% nonfat dry milk. The rabbit polyclonal anti-NGC antibody [<xref ref-type="bibr" rid="r26">26</xref>] and the rabbit polyclonal anti-&#x003b1;-tubulin (H-300) antibody (Santa Cruz Biotechnology, Santa Cruz, CA) were diluted 1:5,000. The secondary ECL&#x02122; donkey anti-rabbit IgG horseradish peroxidase-conjugated antibody was diluted 1:25,000 (GE Healthcare). Proteins were detected by chemiluminescence (ECL Plus Western Blotting Detection System, GE Healthcare) on a Hyperfilm&#x02122; ECL (GE Healthcare). Signals were quantified with Gelquant software Version 2.7.0 (<ext-link ext-link-type="uri" xlink:href="http://www.dnr-is.com">DNR</ext-link> Imaging Systems Ltd., Jerusalem, Israel).</p></sec><sec><title>Statistical analysis</title><p>Statistical analysis was performed on normalized cycle threshold values for quantitative PCR and on raw densitometric data for western blot analysis. Data were analyzed by a two-way ANOVA, using genotype and age factors (Graphpad Prism 4.0.2; GraphPad Software Inc., La Jolla, CA).</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Upregulation of transcripts coding for IPM proteins in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas</title><p>In an initial gene expression profiling experiment using Affymetrix&#x000ae; oligonucleotide microarrays, 534 genes were differentially expressed in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mouse retinas after two, four, and six months of disease progression [<xref ref-type="bibr" rid="r11">11</xref>]. We extended the time-course to up to 18 months (<xref ref-type="fig" rid="f1">Figure 1</xref>, left panels). The genes coding for the reported IPM proteins IMPG2 and CD44 were induced by over 2 fold during disease progression. Additionally, we observed an up to 1.7 fold induction of <italic>NGC</italic> mRNA expression in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas. We validated the oligonucleotide microarray data by quantitative PCR (<xref ref-type="fig" rid="f1">Figure 1</xref>, right panels). At all time points, <italic>NGC</italic> mRNA expression was induced by over 2 fold in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas versus wild-type levels (p&#x0003c;0.01). Additionally, there was a significant decrease in <italic>NGC</italic> mRNA expression over time in both wild-type and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas (p&#x0003c;0.01), consistent with previous observations in developing and adult retinas [<xref ref-type="bibr" rid="r19">19</xref>]. <italic>IMPG2</italic> mRNA levels were induced in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas by 4.2 fold at two months, and decreased progressively to less than 2 fold at 18 months. The mRNA levels for <italic>CD44</italic> were induced in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas by 2.9 fold at two months and remained elevated during disease progression up to 18 months.</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Retinal expression of <italic>NGC</italic>, <italic>IMPG2</italic>, and <italic>CD44</italic> mRNAs in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice. mRNA expression from wild-type (diamonds) and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas (squares) was assessed at 2, 4, 6, 12, and 18 months by oligonucleotide microarray (left panels, n=3) and validated by quantitative PCR (right panels, n=6). A complete description of the oligonucleotide microarray data at 2, 4, and 6 months has been published in [<xref ref-type="bibr" rid="r11">11</xref>]. For quantitative PCR, mRNA expression was normalized to <italic>RL8</italic> mRNA expression. Samples from 2-month-old wild-type mice were arbitrarily set to 1. Fold inductions +/&#x02212; SEM are shown. It was found by two-way ANOVA that mRNA expression levels were significantly different between genotypes for all time points (p&#x0003c;0.01).</p></caption><graphic xlink:href="mv-v14-2126-f1"/></fig></sec><sec><title>Differential expression of <italic>NGC</italic> mRNA isoforms in the eye</title><p>To date, three different <italic>NGC</italic> isoforms have been reported in mice [<xref ref-type="bibr" rid="r18">18</xref>]. They were generated through alternative exon usage in 5&#x02032;. Exon 1 present in <italic>NGC-I</italic> can be replaced by an intronic sequence (exon 1&#x02019;) and yield isoform <italic>NGC-II</italic> (<xref ref-type="fig" rid="f2">Figure 2A</xref>). Additionally, the presence of the alternatively spliced exon 5 results in isoform <italic>NGC-III</italic>. All three <italic>NGC</italic> isoforms were detected in adult mouse brain and eye by isoform-specific PCR (<xref ref-type="fig" rid="f2">Figure 2B</xref>). <italic>NGC-I</italic> levels were highest in the RPE, the retina, and the brain; they were lower in the lens and the cornea. For <italic>NGC-II</italic>, the size of the PCR amplification products from mouse genomic DNA and cDNA were identical. <italic>NGC-II</italic> was barely detected in brain, retina and RPE, but a strong signal was present with mouse genomic DNA. <italic>NGC-III</italic> was detected in a similar pattern than <italic>NGC-I</italic>. <italic>IMPG2</italic> was selectively expressed in the retina, whereas <italic>CD44</italic> was detected in all analyzed tissues. Genomic fragments were also amplified on mouse genomic DNA with primers for <italic>RL8</italic> and <italic>IMPG2</italic>. In contrast to what had been observed for <italic>NGC-II</italic>, these signals were weaker than those amplified from cDNA templates, thus suggesting low<italic> NGC-II</italic> mRNA expression levels. Furthermore, contamination of the cDNA templates by genomic DNA could be excluded by the absence of amplification products corresponding to the <italic>RL8</italic> genomic fragments.</p><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Differential expression of <italic>NGC</italic> mRNA isoforms in the adult mouse eye. <bold>A:</bold> Schematic representation of mouse <italic>NGC</italic> isoforms. Exons are numbered above the scheme. The <italic>NGC-I</italic> isoform contains exon 1 (light gray), that is replaced through alternative splicing by exon 1&#x02019; (dark gray) in the <italic>NGC-II</italic> isoform. An additional exon 5 (black) is present in isoform <italic>NGC-III</italic>. <bold>B:</bold><italic>NGC</italic> isoform mRNA expression in adult mouse tissues. RT&#x02013;PCR experiments were performed on pooled tissues from four different eyes of 8-week-old mice. One representative experiment out of two is shown. <italic>RL8</italic> mRNA expression was used as an internal standard. Abbreviations: retinal pigment epithelium with attached choroid (RPE,C); no template (-RT); 200 ng mouse genomic DNA (gen); DNA molecular weight marker X (MW). Only relevant band sizes are indicated. Specific cDNA amplification yielded products of 452 bp for <italic>NGC-I</italic>, 595 bp for <italic>NGC-II</italic>, 178 bp for NGC-III, 226 bp for <italic>IMPG2</italic>, 250 bp for <italic>CD44</italic>, and 199 bp for <italic>RL8</italic>. Amplification on genomic DNA yielded products of 595 bp for <italic>NGC-II</italic>, 1192 bp for <italic>IMPG2</italic>, and 336 bp for <italic>RL8</italic>.</p></caption><graphic xlink:href="mv-v14-2126-f2"/></fig></sec><sec><title>Differential expression of <italic>NGC</italic> mRNA isoforms in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice</title><p>To assess isoform-specific <italic>NGC</italic> mRNA expression, we performed quantitative PCR experiments on retinas and RPE cells of 2-, 6- and 12-month-old wild-type and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="f3">Figure 3</xref>). <italic>NGC-I</italic> expression was over 2 fold induced in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas at all time points. NGC-I transcripts were around 5 fold to 6 fold more abundant in the RPE than in the retina, but expression levels were not increased in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice. <italic>NGC-II</italic> levels were comparable between wild-type and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice, but at least 16.9 old lower than those of <italic>NGC-I</italic>, with cycle threshold values beyond our threshold of confidence (Ct&#x0003e;34; see Methods; data not shown). In wild-type retinas, <italic>NGC-III</italic> mRNA levels were about 10 fold lower than <italic>NGC-I</italic> levels. They were increased in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas, to a similar extent than that observed for <italic>NGC-I</italic> (p&#x0003c;0.01). <italic>NGC-III</italic> mRNA levels were low in the RPE, but became significantly increased over age (p&#x0003c;0.05).</p><fig id="f3" fig-type="figure" position="float"><label>Figure 3</label><caption><p>Differential expression of <italic>NGC</italic> mRNA isoforms in <italic>Rpe65<sup>&#x02212;/&#x02212;</sup></italic> mice. <italic>NGC-I</italic> (left bars) and <italic>NGC-III</italic> (right bars) mRNA expression was assessed by quantitative PCR on total RNA extracted from wild-type (wt) and <italic>Rpe65<sup>&#x02212;/&#x02212;</sup></italic> mice (ko) at 2, 6, and 12 months (n=3). Left panel shows retinal samples and right panel RPE cell samples. Retinal <italic>NGC-I</italic> mRNA expression (white bars) was compared to <italic>NGC-III</italic> mRNA levels (red bars). Similarly, RPE <italic>NGC-I</italic> mRNA expression (blue bars) was compared to <italic>NGC-III</italic> mRNA levels (green bars). Retinal <italic>NGC-I</italic> mRNA expression of 2-month-old wild-type mice was arbitrarily set to 1. For both panels, fold inductions&#x000b1;SEM are shown. By two-way ANOVA retinal <italic>NGC-I</italic> and <italic>NGC-III</italic> mRNA levels were significantly increased in <italic>Rpe65<sup>&#x02212;/&#x02212;</sup></italic> mice (p&#x0003c;0.01). Increase in <italic>NGC-III</italic> mRNA expression in the RPE was also significant at 6 and 12 months (p&#x0003c;0.05).</p></caption><graphic xlink:href="mv-v14-2126-f3"/></fig></sec><sec><title><italic>NGC</italic> mRNA expression in adult wild-type and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas</title><p>We analyzed <italic>NGC</italic> mRNA expression by in situ hybridization (<xref ref-type="fig" rid="f4">Figure 4</xref>) to exclude the possibility that the observed increase in <italic>NGC</italic> mRNA expression in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas was due to de novo expression in retinal cell populations that do not express <italic>NGC</italic> in wild-type mice. <italic>NGC</italic> mRNA was highly expressed in the ganglion cell layer, in the inner nuclear layer, around the outer limiting membrane, and in the RPE (<xref ref-type="fig" rid="f4">Figure 4A,G</xref>). It was also detected at low levels in the inner plexiform layer and the outer nuclear layer (<xref ref-type="fig" rid="f4">Figure 4A</xref>). We did not observe ectopic <italic>NGC</italic> mRNA expression during disease progression, not even in 6-month-old <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice, where the outer retina was disorganized [<xref ref-type="bibr" rid="r7">7</xref>] (<xref ref-type="fig" rid="f4">Figure 4C-F</xref>).</p><fig id="f4" fig-type="figure" position="float"><label>Figure 4</label><caption><p>In situ hybridization of <italic>NGC</italic> transcripts. In situ hybridization studies were performed on retinal sections of 2-month-old wild-type mice with antisense (<bold>A</bold>) and control sense (<bold>B</bold>) probes. Retinal sections of wild-type (<bold>C,D</bold>) and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> (<bold>E,F</bold>) mice at 2 (<bold>C,E</bold>) and 6 months of age (<bold>D,F</bold>) were hybridized with the antisense probe to detect NGC transcripts. NGC mRNA is expressed in the RPE cell layer (<bold>G</bold>; arrows). Abbreviations: retinal pigment epithelium (rpe): photoreceptor outer segments (pos); outer nuclear layer (onl); outer plexiform layer (opl); inner nuclear layer (inl); inner plexiform layer (ipl); retinal ganglion cell layer (gcl). Scale bars represents 30 &#x003bc;m (<bold>A,B</bold>) and 40 &#x003bc;m (<bold>C-F</bold>).</p></caption><graphic xlink:href="mv-v14-2126-f4"/></fig><p>We also examined mRNA expression of <italic>IMPG2</italic> during disease progression (<xref ref-type="fig" rid="f5">Figure 5</xref>). In wild-type retinas, the mRNA expression pattern of <italic>IMPG2</italic> was comparable to that of <italic>NGC</italic> (<xref ref-type="fig" rid="f5">Figure 5A</xref>). In 2-month-old <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas, increased <italic>IMPG2</italic> mRNA expression was observed at the outer limiting membrane (<xref ref-type="fig" rid="f5">Figure 5E</xref>). At six months, <italic>IMPG2</italic> mRNA expression was decreased at the outer limiting membrane and the inner nuclear layer in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas (<xref ref-type="fig" rid="f5">Figure 5F</xref>), and, to some extent, in wild-type retinas (<xref ref-type="fig" rid="f5">Figure 5D</xref>).</p><fig id="f5" fig-type="figure" position="float"><label>Figure 5</label><caption><p>In situ hybridization of <italic>IMPG2</italic> transcripts. In situ hybridization studies were performed on retinal sections from 2-month-old wild-type mice with antisense (<bold>A</bold>) and control sense (<bold>B</bold>) probes. Retinal sections of wild-type (<bold>C,D</bold>) and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> (<bold>E,F</bold>) mice at 2 (<bold>C,E</bold>) and 6 months of age (<bold>D,F</bold>) were hybridized with the antisense probe to detect <italic>IMPG2</italic> transcripts. Abbreviations: retinal pigment epithelium (rpe); photoreceptor outer segments (pos); outer nuclear layer (onl): outer plexiform layer (opl); inner nuclear layer (inl); inner plexiform layer (ipl); retinal ganglion cell layer. Scale bars equal 30 &#x003bc;m (<bold>A,B</bold>) and 40 &#x003bc;m (<bold>C-F</bold>).</p></caption><graphic xlink:href="mv-v14-2126-f5"/></fig></sec><sec><title>Upregulation of NGC protein expression in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> retinas</title><p>To test whether the observed increase in <italic>NGC</italic> mRNA expression correlated with an increase in NGC protein levels, we performed western blot analysis on total retinal protein extracts of 2-, 4- and 6-month-old wild-type and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="f6">Figure 6</xref>). An antisera raised against the extracellular part of human NGC detected a protein as a smear from about 120 kDa upwards, corresponding to the NGC core protein of 120 kDa with multiple posttranslational modifications [<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r26">26</xref>,<xref ref-type="bibr" rid="r27">27</xref>] (<xref ref-type="fig" rid="f6">Figure 6A</xref>). In retinal protein extracts of 2-month-old mice, and to a lesser extent in 4-month-old mice, a marked increase in the activity-cleaved 75 kDa-ectodomain of NGC was observed (<xref ref-type="fig" rid="f6">Figure 6A</xref>; data not shown). NGC protein levels, i.e., the sum of full-length NGC and the ectodomain, were over 2 fold induced in retinas of <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice at 2 and 4 months of age, but no significant difference was detected at 6 months (<xref ref-type="fig" rid="f6">Figure 6B</xref>).</p><fig id="f6" fig-type="figure" position="float"><label>Figure 6</label><caption><p>NGC protein expression during retinal degeneration in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice. <bold>A:</bold> In the present study, 20 &#x003bc;g of total protein extracts from four pooled retinas of 2-month-old wild-type and <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice were resolved on a 6% SDS&#x02013;PAGE and analyzed by western blot. Posttranslational modifications of the NGC full-length protein resulted in a signal for NGC under appearance of a smear. The asterisk marks the shedded NGC ectodomain of about 75 kDa. <bold>B:</bold> Total protein extracts were prepared from one retina of 2-, 4-, and 6-months (m)-old wild-type (white bars) and <italic>Rpe65<sup>-/-</sup></italic> mice (black bars). NGC expression was assessed by western blot and subsequently quantified (n=3). The sum of NGC full-length and ectodomain signal intensities were normalized to &#x003b1;-tubulin expression. NGC expression was statistically different between wild-type and <italic>Rpe65<sup>-/-</sup></italic> retinas at 2 and 4 months, but not 6 months of age, as assessed by two-way ANOVA (p&#x0003c;0.01) and by Student&#x02019;s <italic>/</italic><italic>t</italic><italic>/</italic>-test.</p></caption><graphic xlink:href="mv-v14-2126-f6"/></fig></sec><sec><title>NGC is highly expressed in the outer retina</title><p>The retinal NGC expression pattern detected by immunohistochemistry with the antisera raised against the entire extracellular domain of NGC [<xref ref-type="bibr" rid="r26">26</xref>] was comparable to that detected with an antisera against a partial ectodomain [<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r28">28</xref>]. NGC was enriched in all neurite-containing retinal layers of adult mouse retina (<xref ref-type="fig" rid="f7">Figure 7A,B</xref>). NGC was expressed in the nerve fiber layer, the inner plexiform layer, and the outer plexiform layer, but was absent in the cell bodies of ganglion cells and in the inner nuclear layer. In the outer neural retina, NGC staining was intense around the outer limiting membrane and was associated with longitudinal structures in the outer nuclear layer (<xref ref-type="fig" rid="f7">Figure 7A,B</xref>). Consistent with the mRNA expression, the highest levels of NGC expression were detected in the RPE (<xref ref-type="fig" rid="f7">Figure 7C</xref>). Counterstaining with a cone-specific lectin showed that NGC immunoreactivity was highest at the apical membranes of RPE cells, surrounding the outer segments of the photoreceptors (<xref ref-type="fig" rid="f7">Figure 7C</xref>).</p><fig id="f7" fig-type="figure" position="float"><label>Figure 7</label><caption><p>NGC protein expression in the adult mouse retina. Immunohistochemical analysis was performed with an antiserum raised against the extracellular part of NGC (red) on retinal sections of 2-month-old wild-type mice (<bold>A</bold>). Nuclei were stained in blue with DAPI, and images were merged (<bold>B</bold>). As a negative control, serum from a nonimmunized rabbit was used; the nuclei were stained with DAPI, and the images were merged (<bold>D</bold>). <bold>C:</bold> NGC is predominantly expressed at the apical side of RPE cells. NGC appears in red, nuclei are in blue, and outer segments of cone photoreceptor cells are in green. Note cone outer segments surrounded by microvilli of RPE cells in yellow (arrows). This image was obtained by filtering the intensity of the fluorescence down to 6.25% for the red channel, by fixing the one of the green channel at 100%. Stars denote three nuclei of RPE cells. Abbreviations: retinal pigment epithelium (rpe); outer nuclear layer (onl); outer plexiform layer (opl); inner nuclear layer (inl); inner plexiform layer (ipl); ganglion cell layer (gcl). Scale bars equal 30 &#x003bc;m.</p></caption><graphic xlink:href="mv-v14-2126-f7"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>In the present work, we showed that <italic>NGC</italic>, <italic>IMPG2</italic>, and <italic>CD44</italic> mRNA expression was induced during retinal degeneration in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice. The amplitude of fold-inductions were similar to those observed for proteoglycans and CD44 in other mouse models of retinal degeneration, namely rd1 (rodless retina), rds (retinal degeneration slow, rd2), and rhodopsin knockout (<italic>Rho</italic><sup>&#x02212;/&#x02212;</sup>) mice [<xref ref-type="bibr" rid="r29">29</xref>-<xref ref-type="bibr" rid="r31">31</xref>]. Upregulation of extracellular matrix proteins expressed in the IPM might therefore be a general mechanism observed in retinal degeneration.</p><p>The induction of <italic>CD44</italic> gene expression had been proposed to be an attempt of the M&#x000fc;ller cells to strengthen the IPM, thereby counteracting the degenerative process [<xref ref-type="bibr" rid="r29">29</xref>]. Elevated <italic>IMPG2</italic> mRNA levels early in retinal degeneration might also be circumstantial evidence of the importance of chondroitin sulfate proteoglycans in the IPM to maintain functional photoreceptors. Indeed, both the inhibition of chondroitin sulfate proteoglycan synthesis by intravitreal injections of p-nitrophenyl-&#x003b2;-D-xylopyranoside and the impairment of &#x003b2;-glucuronidase-mediated lysosomal degradation of chondroitin sulphate, resulted in photoreceptor degeneration [<xref ref-type="bibr" rid="r32">32</xref>,<xref ref-type="bibr" rid="r33">33</xref>]. Notably, at 18 months, when the photoreceptors have almost completely disappeared in the <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice, <italic>IMPG2</italic> mRNA levels were down to levels observed in age-matched wild-type retinas. Consistently, the decrease in <italic>IMPG2</italic> mRNA expression appeared to start from the outer retina toward the inner retina, as suggested by in situ hybridization on 6-month-old retinas.</p><p>In the present work, we identified NGC as an additional chondroitin sulfate proteoglycan expressed in the IPM during retinal degeneration in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice. <italic>NGC-I</italic> was the most highly expressed isoform in the retina and in the RPE. Additionally, mainly <italic>NGC-I</italic> mRNA expression was induced during retinal degeneration in <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice. The low <italic>NGC-II</italic> mRNA expression in brain, retina, and RPE could not be assessed by quantitative PCR. It has to be mentioned at this point, that the presence of a NGC-II protein in the central nervous system has not been assessed to date [<xref ref-type="bibr" rid="r26">26</xref>]. The isoform <italic>NGC-III</italic> was present at low levels both in the retina and the RPE. Taken together, our results define NGC-I as the major isoform in the retina and the RPE.</p><p>At the protein level, we observed a significant induction of NGC expression in retinas as old as four months. Most interestingly, we observed an increase in the shedded ectodomain of NGC in 2- and 4-month-old retinas. This EGF-like-domain-containing ectodomain is sufficient to promote neurite outgrowth from rat neocortical neurons in culture [<xref ref-type="bibr" rid="r21">21</xref>]. Additionally, the full-length NGC is a critical modulator of dendritic branching and spine formation both in cultured primary neurons and in the mouse cortex [<xref ref-type="bibr" rid="r17">17</xref>,<xref ref-type="bibr" rid="r22">22</xref>]. The induction of NGC expression in neurite-containing retinal layers could therefore be an attempt to maintain proper synaptic transmission in the degenerating retina. Recently, tissue inhibitor of metalloproteinases 2 (TIMP-2) and TIMP-3 have been identified in vitro as inhibitors of NGC ectodomain shedding [<xref ref-type="bibr" rid="r34">34</xref>]. It will be interesting to assess the in vivo activity of TIMP-2 and -3 in <italic>RPE65<sup>-/-</sup></italic> retinas and test any physiological effect on ectodomain shedding.</p><p>In the adult eye, NGC was most abundantly expressed at the apical membrane of the RPE. However, its transcript levels were not differentially regulated during retinal degeneration, suggesting the presence of tissue-specific regulatory elements in the <italic>NGC</italic> promoter. Constitutive expression of NGC at the apical membrane of RPE cells might be necessary to modulate the physiologic interactions between the RPE and the photoreceptors, e.g. the phagocytosis of photoreceptor outer segments in the adult retina [<xref ref-type="bibr" rid="r19">19</xref>]. The availability of <italic>NGC</italic><sup>&#x02212;/&#x02212;</sup> mice will allow a detailed analysis of the importance of NGC in maintaining the retinal neuronal network during retinal degeneration in <italic>Rpe65<sup>&#x02212;/&#x02212;</sup></italic> mice [<xref ref-type="bibr" rid="r20">20</xref>].</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Nathalie Voirol for excellent technical assistance. We also thank Dr. T. M. Redmond for the <italic>Rpe65</italic><sup>&#x02212;/&#x02212;</sup> mice and Dr. Bertrand L&#x000e9;ger for help with the gel quantification program. These data were presented as a poster at the ARVO 2008 meeting. This work was supported by a grant from T&#x000e9;l&#x000e9;thon Action Suisse (to P.E.).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>SM</given-names></name><name><surname>Thompson</surname><given-names>DA</given-names></name><name><surname>Srikumari</surname><given-names>CR</given-names></name><name><surname>Lorenz</surname><given-names>B</given-names></name><name><surname>Finckh</surname><given-names>U</given-names></name><name><surname>Nicoletti</surname><given-names>A</given-names></name><name><surname>Murthy</surname><given-names>KR</given-names></name><name><surname>Rathmann</surname><given-names>M</given-names></name><name><surname>Kumaramanickavel</surname><given-names>G</given-names></name><name><surname>Denton</surname><given-names>MJ</given-names></name><name><surname>Gal</surname><given-names>A</given-names></name></person-group><article-title>Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy.</article-title><source>Nat Genet</source><year>1997</year><volume>17</volume><fpage>194</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9326941</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marlhens</surname><given-names>F</given-names></name><name><surname>Bareil</surname><given-names>C</given-names></name><name><surname>Griffoin</surname><given-names>JM</given-names></name><name><surname>Zrenner</surname><given-names>E</given-names></name><name><surname>Amalric</surname><given-names>P</given-names></name><name><surname>Eliaou</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>SY</given-names></name><name><surname>Harris</surname><given-names>E</given-names></name><name><surname>Redmond</surname><given-names>TM</given-names></name><name><surname>Arnaud</surname><given-names>B</given-names></name><name><surname>Claustres</surname><given-names>M</given-names></name><name><surname>Hamel</surname><given-names>CP</given-names></name></person-group><article-title>Mutations in RPE65 cause Leber's congenital amaurosis.</article-title><source>Nat Genet</source><year>1997</year><volume>17</volume><fpage>139</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">9326927</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Moghrabi</surname><given-names>WN</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Travis</surname><given-names>GH</given-names></name></person-group><article-title>Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium.</article-title><source>Cell</source><year>2005</year><volume>122</volume><fpage>449</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">16096063</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redmond</surname><given-names>TM</given-names></name><name><surname>Poliakov</surname><given-names>E</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Tsai</surname><given-names>JY</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Gentleman</surname><given-names>S</given-names></name></person-group><article-title>Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle.</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>13658</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">16150724</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moiseyev</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>BX</given-names></name><name><surname>Ma</surname><given-names>JX</given-names></name></person-group><article-title>RPE65 is the isomerohydrolase in the retinoid visual cycle.</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>12413</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16116091</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moiseyev</surname><given-names>G</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Gentleman</surname><given-names>S</given-names></name><name><surname>Redmond</surname><given-names>TM</given-names></name><name><surname>Crouch</surname><given-names>RK</given-names></name><name><surname>Ma</surname><given-names>JX</given-names></name></person-group><article-title>RPE65 is an iron(II)-dependent isomerohydrolase in the retinoid visual cycle.</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>2835</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">16319067</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redmond</surname><given-names>TM</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Bok</surname><given-names>D</given-names></name><name><surname>Hamasaki</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Goletz</surname><given-names>P</given-names></name><name><surname>Ma</surname><given-names>J-X</given-names></name><name><surname>Crouch</surname><given-names>K</given-names></name><name><surname>Pfeifer</surname><given-names>K</given-names></name></person-group><article-title>Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle.</article-title><source>Nat Genet</source><year>1998</year><volume>20</volume><fpage>344</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">9843205</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seeliger</surname><given-names>MW</given-names></name><name><surname>Grimm</surname><given-names>C</given-names></name><name><surname>St&#x000e5;hlberg</surname><given-names>F</given-names></name><name><surname>Friedburg</surname><given-names>C</given-names></name><name><surname>Jaissle</surname><given-names>G</given-names></name><name><surname>Zrenner</surname><given-names>E</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Rem&#x000e9;</surname><given-names>CE</given-names></name><name><surname>Humphries</surname><given-names>P</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Biel</surname><given-names>M</given-names></name><name><surname>Fariss</surname><given-names>RN</given-names></name><name><surname>Redmond</surname><given-names>TM</given-names></name><name><surname>Wenzel</surname><given-names>A</given-names></name></person-group><article-title>New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis.</article-title><source>Nat Genet</source><year>2001</year><volume>29</volume><fpage>70</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">11528395</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rohrer</surname><given-names>B</given-names></name><name><surname>Goletz</surname><given-names>P</given-names></name><name><surname>Znoiko</surname><given-names>S</given-names></name><name><surname>Ablonczy</surname><given-names>Z</given-names></name><name><surname>Ma</surname><given-names>JX</given-names></name><name><surname>Redmond</surname><given-names>TM</given-names></name><name><surname>Crouch</surname><given-names>RK</given-names></name></person-group><article-title>Correlation of regenerable opsin with rod ERG signal in Rpe65-/- mice during development and aging.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><fpage>310</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12506090</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Znoiko</surname><given-names>SL</given-names></name><name><surname>Rohrer</surname><given-names>B</given-names></name><name><surname>Lu</surname><given-names>K</given-names></name><name><surname>Lohr</surname><given-names>HR</given-names></name><name><surname>Crouch</surname><given-names>RK</given-names></name><name><surname>Ma</surname><given-names>JX</given-names></name></person-group><article-title>Downregulation of cone-specific gene expression and degeneration of cone photoreceptors in the Rpe65<sup>&#x02212;/&#x02212;</sup> mouse at early ages.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2005</year><volume>46</volume><fpage>1473</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15790918</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cottet</surname><given-names>S</given-names></name><name><surname>Michaut</surname><given-names>L</given-names></name><name><surname>Boisset</surname><given-names>G</given-names></name><name><surname>Schlecht</surname><given-names>U</given-names></name><name><surname>Gehring</surname><given-names>W</given-names></name><name><surname>Schorderet</surname><given-names>DF</given-names></name></person-group><article-title>Biological characterization of gene response in Rpe65<sup>&#x02212;/&#x02212;</sup> mouse model of Leber's congenital amaurosis during progression of the disease.</article-title><source>FASEB J</source><year>2006</year><volume>20</volume><fpage>2036</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">17012256</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>S</given-names></name><name><surname>Foletta</surname><given-names>VC</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Rayborn</surname><given-names>ME</given-names></name><name><surname>Rodriguez</surname><given-names>IR</given-names></name><name><surname>Young</surname><given-names>WS</given-names><suffix>III</suffix></name><name><surname>Hollyfield</surname><given-names>JG</given-names></name></person-group><article-title>SPACRCAN, a novel human interphotoreceptor matrix hyaluronan-binding proteoglycan synthesized by photoreceptors and pinealocytes.</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>6945</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">10702256</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>O</given-names></name></person-group><article-title>The retinal pigment epithelium in visual function.</article-title><source>Physiol Rev</source><year>2005</year><volume>85</volume><fpage>845</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">15987797</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaitin</surname><given-names>MH</given-names></name><name><surname>Wortham</surname><given-names>HS</given-names></name><name><surname>Brun-Zinkernagel</surname><given-names>AM</given-names></name></person-group><article-title>Immunocytochemical localization of CD44 in the mouse retina.</article-title><source>Exp Eye Res</source><year>1994</year><volume>58</volume><fpage>359</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">7513650</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hollyfield</surname><given-names>JG</given-names></name></person-group><article-title>Hyaluronan and the functional organization of the interphotoreceptor matrix.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1999</year><volume>40</volume><fpage>2767</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10549633</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>E</given-names></name><name><surname>Maeda</surname><given-names>N</given-names></name><name><surname>Matsui</surname><given-names>F</given-names></name><name><surname>Kushima</surname><given-names>Y</given-names></name><name><surname>Noda</surname><given-names>M</given-names></name><name><surname>Oohira</surname><given-names>A</given-names></name></person-group><article-title>Neuroglycan C, a novel membrane-spanning chondroitin sulfate proteoglycan that is restricted to the brain.</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>26876</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">7592931</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>S</given-names></name><name><surname>Volkmer</surname><given-names>H</given-names></name><name><surname>Buck</surname><given-names>F</given-names></name><name><surname>Otto</surname><given-names>A</given-names></name><name><surname>Tarn&#x000f3;k</surname><given-names>A</given-names></name><name><surname>Roth</surname><given-names>S</given-names></name><name><surname>Rathjen</surname><given-names>FG</given-names></name></person-group><article-title>Chicken acidic leucine-rich EGF-like domain containing brain protein (CALEB), a neural member of the EGF family of differentiation factors, is implicated in neurite formation.</article-title><source>J Cell Biol</source><year>1997</year><volume>136</volume><fpage>895</fpage><lpage>906</lpage><pub-id pub-id-type="pmid">9049254</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aono</surname><given-names>S</given-names></name><name><surname>Keino</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>T</given-names></name><name><surname>Yasuda</surname><given-names>Y</given-names></name><name><surname>Tokita</surname><given-names>Y</given-names></name><name><surname>Matsui</surname><given-names>F</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Sonta</surname><given-names>S</given-names></name><name><surname>Oohira</surname><given-names>A</given-names></name></person-group><article-title>Genomic organization and expression pattern of mouse neuroglycan C in the cerebellar development.</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>337</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">10617623</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inatani</surname><given-names>M</given-names></name><name><surname>Tanihara</surname><given-names>H</given-names></name><name><surname>Oohira</surname><given-names>A</given-names></name><name><surname>Otori</surname><given-names>Y</given-names></name><name><surname>Nishida</surname><given-names>A</given-names></name><name><surname>Honjo</surname><given-names>M</given-names></name><name><surname>Kido</surname><given-names>N</given-names></name><name><surname>Honda</surname><given-names>Y</given-names></name></person-group><article-title>Neuroglycan C, a neural tissue-specific transmembrane chondroitin sulfate proteoglycan, in retinal neural network formation.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2000</year><volume>41</volume><fpage>4338</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">11095636</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>J&#x000fc;ttner</surname><given-names>R</given-names></name><name><surname>More</surname><given-names>MI</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Babich</surname><given-names>A</given-names></name><name><surname>Meier</surname><given-names>J</given-names></name><name><surname>Henning</surname><given-names>M</given-names></name><name><surname>Erdmann</surname><given-names>B</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>EC</given-names></name><name><surname>Otto</surname><given-names>A</given-names></name><name><surname>Grantyn</surname><given-names>R</given-names></name><name><surname>Rathjen</surname><given-names>FG</given-names></name></person-group><article-title>Impaired synapse function during postnatal development in the absence of CALEB, an EGF-like protein processed by neuronal activity.</article-title><source>Neuron</source><year>2005</year><volume>46</volume><fpage>233</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">15848802</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>K</given-names></name><name><surname>Aono</surname><given-names>S</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><name><surname>Kuroda</surname><given-names>Y</given-names></name><name><surname>Ida</surname><given-names>M</given-names></name><name><surname>Tokita</surname><given-names>Y</given-names></name><name><surname>Matsui</surname><given-names>F</given-names></name><name><surname>Oohira</surname><given-names>A</given-names></name></person-group><article-title>Identification of neurite outgrowth-promoting domains of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, and involvement of phosphatidylinositol 3-kinase and protein kinase C signaling pathways in neuritogenesis.</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>24970</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16803884</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brandt</surname><given-names>N</given-names></name><name><surname>Franke</surname><given-names>K</given-names></name><name><surname>Rasin</surname><given-names>MR</given-names></name><name><surname>Baumgart</surname><given-names>J</given-names></name><name><surname>Vogt</surname><given-names>J</given-names></name><name><surname>Khrulev</surname><given-names>S</given-names></name><name><surname>Hassel</surname><given-names>B</given-names></name><name><surname>Pohl</surname><given-names>EE</given-names></name><name><surname>Sestan</surname><given-names>N</given-names></name><name><surname>Nitsch</surname><given-names>R</given-names></name><name><surname>Schumacher</surname><given-names>S</given-names></name></person-group><article-title>The neural EGF family member CALEB/NGC mediates dendritic tree and spine complexity.</article-title><source>EMBO J</source><year>2007</year><volume>26</volume><fpage>2371</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">17431398</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sugita</surname><given-names>S</given-names></name><name><surname>Streilein</surname><given-names>JW</given-names></name></person-group><article-title>Iris pigment epithelium expressing CD86 (B7&#x02013;2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.</article-title><source>J Exp Med</source><year>2003</year><volume>198</volume><fpage>161</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">12835481</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Escher</surname><given-names>P</given-names></name><name><surname>Lacazette</surname><given-names>E</given-names></name><name><surname>Courtet</surname><given-names>M</given-names></name><name><surname>Blindenbacher</surname><given-names>A</given-names></name><name><surname>Landmann</surname><given-names>L</given-names></name><name><surname>Bezakova</surname><given-names>G</given-names></name><name><surname>Lloyd</surname><given-names>KC</given-names></name><name><surname>Mueller</surname><given-names>U</given-names></name><name><surname>Brenner</surname><given-names>HR</given-names></name></person-group><article-title>Synapses form in skeletal muscles lacking neuregulin receptors.</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>1920</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">15976301</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="book">Braissant O, Wahli W. A simplified in situ hybridization protocol using non-radioactive labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica. 1998;10&#x02013;16.</citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aono</surname><given-names>S</given-names></name><name><surname>Tokita</surname><given-names>Y</given-names></name><name><surname>Yasuda</surname><given-names>Y</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><name><surname>Yamauchi</surname><given-names>S</given-names></name><name><surname>Shuo</surname><given-names>T</given-names></name><name><surname>Matsui</surname><given-names>F</given-names></name><name><surname>Keino</surname><given-names>H</given-names></name><name><surname>Kashiwai</surname><given-names>A</given-names></name><name><surname>Kawamura</surname><given-names>N</given-names></name><name><surname>Shimada</surname><given-names>A</given-names></name><name><surname>Kishikawa</surname><given-names>M</given-names></name><name><surname>Asai</surname><given-names>M</given-names></name><name><surname>Oohira</surname><given-names>A</given-names></name></person-group><article-title>Expression and identification of a new splice variant of neuroglycan C, a transmembrane chondroitin sulfate proteoglycan, in the human brain.</article-title><source>J Neurosci Res</source><year>2006</year><volume>83</volume><fpage>110</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16299773</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aono</surname><given-names>S</given-names></name><name><surname>Tokita</surname><given-names>Y</given-names></name><name><surname>Shuo</surname><given-names>T</given-names></name><name><surname>Yamauchi</surname><given-names>S</given-names></name><name><surname>Matsui</surname><given-names>F</given-names></name><name><surname>Nakanishi</surname><given-names>K</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><name><surname>Sano</surname><given-names>M</given-names></name><name><surname>Oohira</surname><given-names>A</given-names></name></person-group><article-title>Glycosylation site for chondroitin sulfate on the neural part-time proteoglycan, neuroglycan C.</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>46536</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">15331613</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>Y</given-names></name><name><surname>Tokita</surname><given-names>Y</given-names></name><name><surname>Aono</surname><given-names>S</given-names></name><name><surname>Matsui</surname><given-names>F</given-names></name><name><surname>Ono</surname><given-names>T</given-names></name><name><surname>Sonta</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>E</given-names></name><name><surname>Nakanishi</surname><given-names>Y</given-names></name><name><surname>Oohira</surname><given-names>A</given-names></name></person-group><article-title>Cloning and chromosomal mapping of the human gene of neuroglycan C (NGC), a neural transmembrane chondroitin sulfate proteoglycan with an EGF module.</article-title><source>Neurosci Res</source><year>1998</year><volume>32</volume><fpage>313</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">9950058</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kennan</surname><given-names>A</given-names></name><name><surname>Aherne</surname><given-names>A</given-names></name><name><surname>Palfi</surname><given-names>A</given-names></name><name><surname>Humphries</surname><given-names>M</given-names></name><name><surname>McKee</surname><given-names>A</given-names></name><name><surname>Stitt</surname><given-names>A</given-names></name><name><surname>Simpson</surname><given-names>DAC</given-names></name><name><surname>Demtroder</surname><given-names>K</given-names></name><name><surname>Orntoft</surname><given-names>T</given-names></name><name><surname>Ayuso</surname><given-names>C</given-names></name><name><surname>Kenna</surname><given-names>PF</given-names></name><name><surname>Farrar</surname><given-names>GJ</given-names></name><name><surname>Humphries</surname><given-names>P</given-names></name></person-group><article-title>Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho<sup>&#x02212;/&#x02212;</sup> mice.</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><fpage>547</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">11875049</pub-id></citation></ref><ref id="r30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hackam</surname><given-names>AS</given-names></name><name><surname>Strom</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Otteson</surname><given-names>D</given-names></name><name><surname>Gunatilaka</surname><given-names>T</given-names></name><name><surname>Farkas</surname><given-names>RH</given-names></name><name><surname>Chowers</surname><given-names>I</given-names></name><name><surname>Kageyama</surname><given-names>M</given-names></name><name><surname>L&#x000e9;veillard</surname><given-names>T</given-names></name><name><surname>Sahel</surname><given-names>J-A</given-names></name><name><surname>Campochioro</surname><given-names>PA</given-names></name><name><surname>Parmigiani</surname><given-names>G</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name></person-group><article-title>Identification of gene expression changes associated with the progression of retinal degeneration in the <italic>rd1</italic> mouse.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2004</year><volume>45</volume><fpage>2929</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">15326104</pub-id></citation></ref><ref id="r31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaitin</surname><given-names>MH</given-names></name><name><surname>Ankrum</surname><given-names>MT</given-names></name><name><surname>Wortham</surname><given-names>HS</given-names></name></person-group><article-title>Distribution of CD44 in the retina during development and the rds degeneration.</article-title><source>Brain Res Dev Brain Res</source><year>1996</year><volume>94</volume><fpage>92</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8816281</pub-id></citation></ref><ref id="r32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lazarus</surname><given-names>HS</given-names></name><name><surname>Hageman</surname><given-names>GS</given-names></name></person-group><article-title>Xyloside-induced disruption of interphotoreceptor matrix proteoglycans results in retinal detachment.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1992</year><volume>33</volume><fpage>364</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">1740367</pub-id></citation></ref><ref id="r33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lazarus</surname><given-names>HS</given-names></name><name><surname>Sly</surname><given-names>WS</given-names></name><name><surname>Kyle</surname><given-names>JW</given-names></name><name><surname>Hageman</surname><given-names>GS</given-names></name></person-group><article-title>Photoreceptor degeneration and altered distribution of interphotoreceptor matrix proteoglycans in the mucopolysaccharidosis VII mouse.</article-title><source>Exp Eye Res</source><year>1993</year><volume>56</volume><fpage>531</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">8500564</pub-id></citation></ref><ref id="r34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shuo</surname><given-names>T</given-names></name><name><surname>Aono</surname><given-names>S</given-names></name><name><surname>Nakanishi</surname><given-names>K</given-names></name><name><surname>Tokita</surname><given-names>Y</given-names></name><name><surname>Kuroda</surname><given-names>Y</given-names></name><name><surname>Ida</surname><given-names>M</given-names></name><name><surname>Matsui</surname><given-names>F</given-names></name><name><surname>Maruyama</surname><given-names>H</given-names></name><name><surname>Kaji</surname><given-names>T</given-names></name><name><surname>Oohira</surname><given-names>A</given-names></name></person-group><article-title>Ectodomain shedding of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, by TIMP-2- and TIMP-3-sensitive proteolysis.</article-title><source>J Neurochem</source><year>2007</year><volume>102</volume><fpage>1561</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17532789</pub-id></citation></ref></ref-list></back></article> 